Camlin Fine Sciences Limited — Important, 13-03-2025: Updates

Camlin Fine Sciences Limited (CFSL) has entered into an agreement to acquire a majority stake in Vinpai S.A., with a transaction structured for payment in newly issued ordinary shares of CFSL at a price of €3.60 per Vinpai share. This acquisition will include shares held by significant shareholders representing 78.68% of Vinpai's share capital. Concurrently, CFSL subscribed to convertible bonds valued at €3.3 million, which will convert upon the acquisition's completion. Following this, CFSL anticipates launching a simplified cash tender offer for the remaining Vinpai shares at the same acquisition price. This strategic move positions CFSL to control approximately 83.82% of Vinpai’s share capital post-transaction, enhancing its market presence in the flavor and wellness sector. Investors should note the potential growth opportunities arising from this acquisition while monitoring any regulatory approvals and market response closely.